- Home
- ARWR vs ESNT Comparison
ARWR vs ESNT Comparison
Compare ARWR & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARWR | ESNT |
|---|---|---|
| Founded | 2003 | 2008 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.9B |
| IPO Year | 1993 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ARWR | ESNT |
|---|---|---|
| Price | $70.94 | $64.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | $60.70 | ★ $66.80 |
| AVG Volume (30 Days) | ★ 3.3M | 558.5K |
| Earning Date | 11-25-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 1.92% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.87 |
| Revenue | $829,448,000.00 | ★ $1,263,558,000.00 |
| Revenue This Year | N/A | $3.87 |
| Revenue Next Year | N/A | $1.55 |
| P/E Ratio | ★ N/A | $9.38 |
| Revenue Growth | ★ 23258.15 | 2.04 |
| 52 Week Low | $9.57 | $51.61 |
| 52 Week High | $72.36 | $65.90 |
Technical Indicators
Market Signals| Indicator | ARWR | ESNT |
|---|---|---|
| Relative Strength Index (RSI) | 78.58 | 66.02 |
| Support Level | $60.29 | $61.25 |
| Resistance Level | $71.50 | $62.35 |
| Average True Range (ATR) | 5.14 | 1.01 |
| MACD | 1.73 | 0.13 |
| Stochastic Oscillator | 95.82 | 95.79 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About ESNT Essent Group Ltd.
Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.